quinazolines has been researched along with Burns, Chemical in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Q; Li, JJ; Li, XM; Lu, C; Tao, SY; Yan, B; Yao, J; Zhang, QY | 1 |
| Doğusoy, G; Gümüştaş, K; Ozçelik, MF; Pekmezci, S; Saribeyoğlu, K; Unal, E | 1 |
| Arbell, D; Genina, O; Koplewitz, BZ; Nagler, A; Ohana, M; Pines, M; Udassin, R | 1 |
3 other study(ies) available for quinazolines and Burns, Chemical
| Article | Year |
|---|---|
SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo.
Topics: Animals; Burns, Chemical; Cell Movement; Cell Proliferation; Cornea; Corneal Diseases; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred ICR; Neovascularization, Physiologic; Ophthalmic Solutions; Quinazolines; Signal Transduction; Thiadiazoles; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of esophageal strictures related to caustic injury.
Topics: Animals; Burns, Chemical; Caustics; Collagen Type I; Esophageal Stenosis; Esophagus; Fibrosis; Injections, Intraperitoneal; Male; Models, Animal; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Sodium Hydroxide | 2004 |
Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis.
Topics: Animals; Burns, Chemical; Caustics; Collagen Type I; Esophageal Stenosis; In Vitro Techniques; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Radiography; Rats; Sodium Hydroxide; Transforming Growth Factor beta; Wound Healing | 2005 |